Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Hydroxychloroquine vs Nitazoxanide + Hydroxychloroquine in Patients With COVID-19 With Risk Factors for Poor Outcome

NCT04341493 is registered in ClinicalTrials.gov with Hugo Mendieta Zeron as lead sponsor.

NCT NCT04341493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Hydroxychloroquine vs Nitazoxanide + Hydroxychloroquine in Patients With COVID-19 With Risk Factors for Poor Outcome
Lead sponsor
Hugo Mendieta Zeron
Phase
Phase 4
Overall status
Terminated
Start date
April 6, 2020
Completion date
December 30, 2020
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection